Home
Clinical Advisory Board
Clinical Advisory Board

Pharmacyclics Clinical Advisory Board

Mark C. Genovese, MD – Stanford University Medical Center Professor of medicine and Co-Chief of the Division of Immunology and Rheumatology

Bart Kamen, M.D., Ph.D. – Robert Wood Johnson Medical Center Professor of Pediatrics and Pharmacology

Minesh P. Mehta, M.D. – University of Wisconsin –Professor and Chairman in the Department of Human Oncology

Frederick Rickles, M.D., F.A.C.P. – The George Washington University Medical Center
Professor of Medicine and Pediatrics; Associate Vice President for Research; and Attending Physician at the George Washington University Hospital and Children’s National Medical Center

Edward A. Sausville, M.D., Ph.D. – University of Maryland – Greenebaum Cancer Center
Professor of Medicine and Associate Director for Clinical Research

Branimir Sikic, M.D. – Stanford University Co-Director, Stanford Center for Clinical and Translational Education; and Research Director, Clinical and Translational Research Unit

David Smith, Ph.D. – City of Hope, Duarte Associate Research Scientist, Biostatistics;
Associate Member, Cancer Biology Program, Comprehensive Cancer Center

Margaret A. Tempero, MD – University of California at San Francisco
Deputy Director of the Comprehensive Cancer Center; and Professor and Chief of the Division of Medical Oncology

Dan von Hoff, M.D. F.A.C.P. – Translational Genomics Research Institute (TGen)
Senior Investigator and Head of Translational Research at TGen; Chief Scientific Officer for US Oncology and the Scottsdale Clinical Research Institute

Steven D. Weitman, MD, Ph.D – Consulting Oncologist
Board certified in Pediatric Hematology/Oncology